Home | Bias 32% Exposed--raw data versus journal articles | FDA in Crisis | Wrong Drugs Used in Dementia | Bisphonphonates & Calcitonin for Osteoporosis don't work | Antidepressants don't work | Drug ads make people sick | adverse drug reactions--frequency | Atrovent (ipratropium) another killer | Anemia drugs Epoetin and Procrit kill | drugs and cognitive impairment | Lunesta, a sleeping pill, with negative results | DIABETES DRUG KILLS | Zyprexa weight gain, Lilly sued | Darvocet pulled in GB, but not here | Leading Researcher Creates Favorable Data
Leading Researcher Creates Favorable Data

Drug News--disappointing

More on VIOXX family of drugs (COX-2 pain inhibitors), another example of as to why a dam should be built between the company researching a potential drug and the clinical trials.  Research fraud is the norm because we have a profit-driven drug industry.  Research is viewed as a marketing tool, and they sponsor and support over 90% of the research leading to published articles.  Pfizer spokes person cries ignorance, but the industry record thunders differently.  Over an over again abuse of science is reported, but nothing changes.  Inventing data is just one way to cook the results, a thing the industry does as standard practice.  A recent study showed, using a comparison of raw data to the published journal and found the distortion at 32%.  Not only are these drugs ineffective at treating acute pain, they have caused of 50,000 deaths U.S. through the acceleration of atherosclerosis.




Doctor Admits Pain Studies Were Frauds, Hospital Says

The New York Times


http://www.nytimes.com/2009/03/11/health/research/11pain.html?ref=health By Gardner Harris, March 10.2009

In what may be among the longest-running and widest-ranging cases of academic fraud,* one of the most prolific researchers in anesthesiology has admitted that he fabricated much of the data underlying his research, said a spokeswoman for the hospital where he works.

The researcher, Dr. Scott S. Reuben, an anesthesiologist in Springfield, Mass., who practiced at Baystate Medical Center, never conducted the clinical trials that he wrote about in 21 journal articles dating from at least 1996, said Jane Albert, a spokeswoman for Baystate Health.

The reliability of dozens more articles he wrote is uncertain, and the common practice — supported by his studies — of giving patients aspirin-like drugs and neuropathic pain medicines after surgery instead of narcotics is now being questioned.

Paul Cirel, a lawyer for Dr. Reuben, said that he could not discuss the case because Baystate had investigated it as part of a confidential peer-review process. Baystate officials “were aware of extenuating circumstances,” Mr. Cirel said.

The drug giant Pfizer underwrote much of Dr. Reuben’s research from 2002 to 2007. Many of his trials found that Celebrex and Lyrica, Pfizer drugs, were effective against postoperative pain.

“Independent clinical research advances disease treatments and improves the lives of patients,” said Raymond F. Kerins Jr., a Pfizer spokesman. “As part of such research, we count on independent researchers to be truthful and motivated by a desire to advance care for patients. It is very disappointing to learn about Dr. Scott Reuben’s alleged actions.”

Drug companies routinely hire community physicians to conduct studies of already-approved medicines. In some cases, prosecutors have charged companies with underwriting studies of little scientific merit in hopes of persuading doctors to prescribe the medicines more often.

“When researchers are beholden to companies for much of their income, there is an incredible tendency to get results that are favorable to the company,” said Dr. Jerome Kassirer, a former editor of The New England Journal of Medicine and the author of a book about conflicts of interest.

Dr. Reuben’s activities were spotted by Baystate after questions were raised about two study abstracts that he filed last spring, Ms. Albert said. The health system determined that he had not received approval to conduct human research, Ms. Albert said.

Baystate investigators determined that Dr. Reuben had concocted data for 21 studies, and the health system asked the journals in which those studies were published to withdraw them.

Dr. Steve Shafer, the editor in chief of Anesthesia & Analgesia, which published many of the papers, said he was considering withdrawing any study in which Dr. Reuben served a pivotal role.

“He was one of the most prolific investigators in the area of postoperative pain management,” Dr. Shafer said. His fraud “sets back our knowledge in the field tremendously.”


*  Why isn’t big PhARMA’s cooking the raw data in the journal articles—along with the researchers who sign their name to the articles considered academic fraud???  Standard practice endorsed by advertisers isn’t an excuse for scientific fraud. 

Enter supporting content here

Those who have a financial interest in the outcome manipulate the results